GlyTR1 target expression in cell-surface vimentin-positive (CSV+) Ewing sarcoma cells was significantly greater than in TNBC (clone 11) cells, and >95% were killed by GlyTR1 in the ALI organoid despite the terminally exhausted TILs (Figure 5H). The gene discussed is VIM; the disease is Ewing sarcoma.